Cetirizine DI HCL

Public-database records for Cetirizine DI HCL (CAS 83881-52-1), reproduced here for independent cross-checking.

Safety classification and hazard statements

Physical description and handling notes

• 198.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

How this substance is indexed

Documented uses

• For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria
• Breast Feeding; Lactation; Milk, Human; Antihistamines
• Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)
• Increased Histamine Release [PE]; Cell-mediated Immunity [PE]; Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]; Allergens [CS]
• Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
• Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

Names this substance appears under

Cetirizine dihydrochloride; 83881-52-1; CETIRIZINE HYDROCHLORIDE; 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride; Cetrine; Cetirizine HCl; Formistin; Alleroff; Zerviate; Allergy relief; Zyrtec Allergy; Zyrtec Hives Relief; P 071; P-071; Topcare all day allergy; Children's Zyrtec Allergy

Computed molecular descriptors

Database abstract

Cetirizine DI HCL · CAS 83881-52-1 · C21H27Cl3N2O3. UNII 64O047KTOA.

Source: PubChem / Wikidata; the batch COA governs where values differ.